desipramine has been researched along with Dominant Hereditary Sensory Neuropathy, Type III in 1 studies
Desipramine: A tricyclic dibenzazepine compound that potentiates neurotransmission. Desipramine selectively blocks reuptake of norepinephrine from the neural synapse, and also appears to impair serotonin transport. This compound also possesses minor anticholinergic activity, through its affinity to muscarinic receptors.
desipramine : A dibenzoazepine consisting of 10,11-dihydro-5H-dibenzo[b,f]azepine substituted on nitrogen with a 3-(methylamino)propyl group.
Excerpt | Relevance | Reference |
---|---|---|
"Desipramine-treated subjects had decreased uptake but normal loss of 6-[(18)F]fluorodopamine-derived radioactivity." | 1.35 | Cardiac sympathetic hypo-innervation in familial dysautonomia. ( Axelrod, FB; Eldadah, B; Goldstein, DS; Sharabi, Y, 2008) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Goldstein, DS | 1 |
Eldadah, B | 1 |
Sharabi, Y | 1 |
Axelrod, FB | 1 |
1 other study available for desipramine and Dominant Hereditary Sensory Neuropathy, Type III
Article | Year |
---|---|
Cardiac sympathetic hypo-innervation in familial dysautonomia.
Topics: Adult; Antidepressive Agents, Tricyclic; Case-Control Studies; Catecholamines; Desipramine; Dopamine | 2008 |